Paper,ADC Name,mAb,Linker,Payload,Conjugate Type,DAR,Drug Status
ref2,Zilovertamab vedotin,Humanized IgG1 monoclonal anti-ROR1;Anti-ROR1 IgG1,Proteolytically cleavable linker,MMAE; Monomethyl auristatin E; Monomethylauristatin E; monomethyl auristatin E; mono-methyl auristatin E; me-AE; auristatin E mono-methyl; SGN-35 payload,N/A,N/A,Phase 2
ref4,BL-B01D1,EGFRxHER3 bispecific antibody,Cleavable linker,Novel TOP-I inhibitor;TOP-I inhibitor,N/A,N/A,Phase 1
ref5,Zilovertamab vedotin,Humanized IgG1 monoclonal anti-ROR1;Anti-ROR1 IgG1,Proteolytically cleavable linker,Antimicrotubule agent monomethyl auristatin E;MMAE; Monomethyl auristatin E; Monomethylauristatin E; monomethyl auristatin E; mono-methyl auristatin E; me-AE; auristatin E mono-methyl; SGN-35 payload,N/A,N/A,Phase 2
